First United Bank & Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.51K Hold
22
﹤0.01% 346
2026
Q1
$6.44K Hold
22
﹤0.01% 339
2025
Q4
$7.71K Hold
22
﹤0.01% 332
2025
Q3
$7.11K Hold
22
﹤0.01% 353
2025
Q2
$8.56K Hold
22
﹤0.01% 314
2025
Q1
$9.57K Hold
22
﹤0.01% 315
2024
Q4
$8.12K Hold
22
﹤0.01% 319
2024
Q3
$11.4K Sell
22
-103
-82% -$55K ﹤0.01% 305
2024
Q2
$67.7K Hold
125
0.03% 207
2024
Q1
$64.8K Hold
125
0.02% 215
2023
Q4
$58.9K Buy
+125
New +$57.8K 0.02% 224

Other funds holding ELV

First United Bank & Trust's ELV Position: Q2 2026 in Review

First United Bank & Trust held its Elevance Health (ELV) position steady in Q2 2026 at 22 shares worth $8.51K. The position accounts for ﹤0.01% of the portfolio, ranked #346.

First United Bank & Trust first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $67.7K in Q2 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • First United Bank & Trust held 22 shares of Elevance Health worth $8.51K as of Q2 2026.
  • First United Bank & Trust left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of First United Bank & Trust's portfolio in Q2 2026, its #346 holding.
  • First United Bank & Trust first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • First United Bank & Trust's Elevance Health position peaked at $67.7K in Q2 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on First United Bank & Trust's 13F filing for Q2 2026, filed 20 Jul 2026.